A detailed history of Deutsche Bank Ag\ transactions in Neogenomics Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 115,356 shares of NEO stock, worth $1.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
115,356
Previous 89,476 28.92%
Holding current value
$1.89 Million
Previous $1.24 Million 37.07%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$13.4 - $17.73 $346,792 - $458,852
25,880 Added 28.92%
115,356 $1.7 Million
Q2 2024

Aug 14, 2024

SELL
$13.01 - $15.77 $154,415 - $187,174
-11,869 Reduced 11.71%
89,476 $1.24 Million
Q1 2024

May 15, 2024

BUY
$14.06 - $16.79 $25,406 - $30,339
1,807 Added 1.82%
101,345 $1.59 Million
Q4 2023

Feb 14, 2024

SELL
$11.67 - $20.73 $17,680 - $31,405
-1,515 Reduced 1.5%
99,538 $1.61 Million
Q3 2023

Nov 09, 2023

BUY
$12.15 - $17.85 $79,837 - $117,292
6,571 Added 6.95%
101,053 $1.24 Million
Q2 2023

Aug 14, 2023

SELL
$14.1 - $19.83 $414,497 - $582,942
-29,397 Reduced 23.73%
94,482 $1.52 Million
Q1 2023

May 15, 2023

BUY
$9.09 - $19.45 $435,311 - $931,441
47,889 Added 63.02%
123,879 $2.16 Million
Q4 2022

Feb 13, 2023

BUY
$6.45 - $12.07 $79,367 - $148,521
12,305 Added 19.32%
75,990 $702,000
Q3 2022

Nov 14, 2022

BUY
$7.86 - $12.91 $1,100 - $1,807
140 Added 0.22%
63,685 $548,000
Q2 2022

Aug 11, 2022

SELL
$7.06 - $13.97 $453,301 - $896,971
-64,207 Reduced 50.26%
63,545 $518,000
Q1 2022

May 13, 2022

SELL
$12.15 - $35.28 $112,375 - $326,304
-9,249 Reduced 6.75%
127,752 $1.55 Million
Q4 2021

Feb 11, 2022

BUY
$30.49 - $48.49 $1.64 Million - $2.61 Million
53,794 Added 64.65%
137,001 $4.67 Million
Q3 2021

Nov 04, 2021

SELL
$41.66 - $52.52 $782,333 - $986,273
-18,779 Reduced 18.41%
83,207 $4.01 Million
Q2 2021

Aug 11, 2021

SELL
$36.62 - $51.69 $3.52 Million - $4.96 Million
-95,989 Reduced 48.49%
101,986 $4.61 Million
Q1 2021

May 13, 2021

BUY
$41.56 - $59.88 $4.55 Million - $6.55 Million
109,412 Added 123.54%
197,975 $9.55 Million
Q4 2020

Feb 16, 2021

SELL
$36.08 - $56.47 $3.94 Million - $6.17 Million
-109,320 Reduced 55.24%
88,563 $4.77 Million
Q3 2020

Nov 12, 2020

BUY
$33.26 - $40.48 $4.49 Million - $5.46 Million
134,998 Added 214.67%
197,883 $7.3 Million
Q2 2020

Aug 13, 2020

SELL
$24.21 - $31.02 $5.19 Million - $6.65 Million
-214,501 Reduced 77.33%
62,885 $1.95 Million
Q1 2020

May 14, 2020

BUY
$20.5 - $34.53 $2.95 Million - $4.96 Million
143,704 Added 107.5%
277,386 $7.66 Million
Q4 2019

Feb 14, 2020

SELL
$18.96 - $29.84 $681,668 - $1.07 Million
-35,953 Reduced 21.19%
133,682 $3.91 Million
Q3 2019

Nov 14, 2019

BUY
$19.12 - $26.24 $479,376 - $657,889
25,072 Added 17.34%
169,635 $3.24 Million
Q2 2019

Aug 14, 2019

BUY
$19.57 - $24.1 $1.41 Million - $1.73 Million
71,851 Added 98.82%
144,563 $3.17 Million
Q1 2019

May 15, 2019

SELL
$12.14 - $20.46 $1.33 Million - $2.24 Million
-109,545 Reduced 60.1%
72,712 $1.49 Million
Q4 2018

Feb 14, 2019

BUY
$11.24 - $18.5 $436,853 - $719,021
38,866 Added 27.1%
182,257 $2.3 Million
Q3 2018

Dec 21, 2021

BUY
$12.5 - $15.38 $200,562 - $246,772
16,045 Added 12.6%
143,391 $2.2 Million
Q3 2018

Nov 14, 2018

BUY
$12.5 - $15.38 $200,012 - $246,095
16,001 Added 14.37%
127,346 $1.95 Million
Q2 2018

Apr 21, 2020

BUY
$7.99 - $14.05 $167,470 - $294,488
20,960 Added 23.19%
111,345 $1.46 Million
Q2 2018

Aug 14, 2018

SELL
$7.99 - $14.05 $83,799 - $147,356
-10,488 Reduced 10.4%
90,385 $1.18 Million
Q1 2018

Oct 18, 2019

BUY
$7.23 - $8.76 $131,708 - $159,580
18,217 Added 22.04%
100,873 $822,000
Q1 2018

May 15, 2018

SELL
$7.23 - $8.76 $390,557 - $473,206
-54,019 Reduced 39.52%
82,656 $673,000
Q4 2017

Feb 14, 2018

BUY
$8.02 - $11.18 $601,884 - $839,036
75,048 Added 121.78%
136,675 $1.21 Million
Q3 2017

Nov 14, 2017

BUY
$9.11 - $11.26 $561,421 - $693,920
61,627
61,627 $683,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.06B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.